Early Alzheimer’s Carers

Early Alzheimer's Clinical Trials

Join Our Early Alzheimer's Clinical Research Trial

We are conducting a clinical trial to evaluate a new investigational medicine for people with early Alzheimer’s disease (AD). Alzheimer’s is the most common cause of memory loss and dementia worldwide, and its impact continues to grow. Recent studies suggest that treating AD in its early stages can be most effective

Study Overview
Purpose: This study aims to assess how well a new investigational medicine works, how safe it is, and how well it is tolerated compared to a placebo. We are focusing on delaying the progression of Alzheimer’s symptoms.

Who Can Participate?
We are looking for:

  • Adults aged 50 to 80.
  • Diagnosed with mild cognitive impairment (MCI) or mild Alzheimer’s dementia.

Study Duration
This study will last for 8 weeks.

Additional Information: Participants can have a loved one or caregiver join them as a study partner. Join us in exploring new pathways that could make a difference for those living with early Alzheimer’s. 

Eligibility Checker:

By clicking submit, you are confirming that you have read & understood the Privacy Policy